Viewing Study NCT00580320


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-02-27 @ 4:06 PM
Study NCT ID: NCT00580320
Status: COMPLETED
Last Update Posted: 2016-08-18
First Post: 2007-12-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma
Sponsor: Virginia Commonwealth University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
None Soft Tissue Sarcoma View
None Parathyroid Carcinoma View
None Small Cell Carcinoma of the Lung View
None Carcinoid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None melanoma View
None soft tissue sarcoma View
None APUD tumor View
None dacarbazine View
None bortezomib View
None velcade View